Organisation
Department of Basic and Applied Medical Sciences
Department
Current researchers
71 - 71 of 71 results
- Rita de Cassia de Oliveira Collaco (Member)
Projects
71 - 80 of 80
- Connexin and pannexine channels: molecular insights to applications in health and disease.From1 Jan 2015 → 31 Dec 2021Funding: FWO scientific research network
- Cell-cell communication in the neurogliovascular unit at the level of the blood-brain barrier: focus on endothelial-glial interactions, inflammation and the role of Ca2+ and connexinsFrom1 Jan 2015 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Combining experimental and computational approaches to investigate arrhythmogenic consequences of connexin hemichannel opening in the heart.From1 Oct 2014 → 29 Feb 2020Funding: BOF - Doctoral projects
- Photoactivation of caged compounds and live cell confocal calcium imaging at the subcellular level.From1 Sep 2014 → 31 Aug 2020Funding: Hercules - Large scale research infrastructure
- hemichannels as novel drug targets in liver fibrosis 2014From1 Jan 2014 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- (De)constructing health news: a transdisciplinary investigation into news media coverage of elderly-related issues.From1 Jan 2014 → 31 Mar 2021Funding: BOF - Concerted Research Project from 1994
- Mechanisms underlying connexin-mediated bystander cell death.From1 Oct 2013 → 30 Sep 2017Funding: BOF - Doctoral projects
- The role of connexin hemichannels in cardiac arrhythmogenesisFrom1 Jan 2013 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- The role of connexin-mediated intercellular signaling in the spread of danger and death signals between brain endothelial cellsFrom1 Jan 2013 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Alliance Research Group: Connexin Signalling Research GroupFrom15 Sep 2011 → 31 Jul 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 1657
- Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma(2016)
Authors: Tijl Vermassen, M. Van de Walle, Sylvie Rottey
Pages: 12 - 18 - REACT expanded-access program in patients with metastatic renal cell carcinoma : real-world data from a European subanalysis(2015)
Authors: S Bracarda, Sylvie Rottey, A Bahl, C Eichelberg, B Mellado, L Mangel, A Cattaneo, A Panneerselvam, V Grunwald
Pages: 2893 - 2903 - Mobile health technology captures 'in-house' data on the outside : an assessment with pharmacological intervention(2019)Volume: 105
Authors: G Bhatia, Q Huang, T Crumley, C Walters, L Cluckers, I Heirman, L Mixson, Sylvie Rottey, M Cantor, C Benko, et al.
Pages: S73 - S73 - Glycosylation of urinary prostate proteins and its potential diagnostic applications(2017)
Authors: Tijl Vermassen
Pages: 126 - 128 - Phase 1 study of AMG 160, a half-life extended BITE (R) (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer(2020)Volume: 8
Authors: Tanya Dorff, Matthew Rettig, Jean-Pascal Machiels, Martijn Lolkema, Karen Autio, Richard Greil, Sylvie Rottey, Nabil Adra, Mark Salvati, Shirley Poon, et al.
Pages: A207 - A208 - Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial(2022)
Authors: Yasmin AbuU+2010Ghanem, Johannes V. Thienen, Christian Blank, Maureen J. B. Aarts, Michael Jewett, Igle Jan Jong, JeanU+2010Baptiste Lattouf, Harm H. E. Melick, Lori Wood, Peter Mulders, et al.
Pages: 68 - 75 - Nephrotoxicity of anticancer drugs: an underestimated problem?(2011)
Authors: VIBEKE KRUSE, Sylvie Rottey
Pages: 337 - 345 - Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial(2013)
Authors: Jan B Vermorken, Jan Stoelmacher-Williams, Irina Davidenko, Lisa Licitra, Eric Winquist, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Krzysztof Skladowski, Makoto Tahara, et al.
Pages: 697 - 710 - A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors(2020)Volume: 80
Authors: Juanita S. Lopez, Ross Camidge, Marco Iafolla, Sylvie Rottey, Martin Schuler, Matthew Hellmann, Ani Balmanoukian, Luc Dirix, Michael Gordon, Ryan Sullivan, et al.
Number of pages: 1 - Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial(2019)
Authors: Axel Bex, Peter Mulders, Michael Jewett, John Wagstaff, Johannes V van Thienen, Christian U Blank, Roland van Velthoven, Maria del Pilar Laguna, Lori Wood, Harm HE van Melick, et al.
Pages: 164 - 170